A robot intervention for adults with ADHD and insomnia

ISRCTN ISRCTN11007746
DOI https://doi.org/10.1186/ISRCTN11007746
Submission date
29/03/2023
Registration date
29/03/2023
Last edited
09/10/2023
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Mental and Behavioural Disorders
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Background and study aims
The study looks at individual effects and experiences of a sleep robot intervention in adults with ADHD and insomnia. Different methods to collect data were used such as sleep diaries, wrist actigraphy, questionnaires, and individual interviews.

Who can participate?
Adults aged over 18 years with ADHD and insomnia.

What does the study involve?
A three-week at-home intervention with the Somnox sleep robot.

What are the possible benefits and risks of participating?
The main possible benefit was reduced insomnia symptoms. Risks with participation included the individuals’ experiences of invasion of privacy when sensitive questions about psychiatric symptoms and well-being are asked. However, the outcome measures of the current study have been used in many studies without any known complications concerning the character of the questions.

Where is the study run from?
Karlstad University (Sweden).

When is the study starting and how long is it expected to run for?
December 2020 to June 2022.

Who is funding the study?
Karlstad University (Sweden)

Who is the main contact?
Mrs Siri Jakobsson Støre
siri.store@kau.se

Contact information

Mrs Siri Jakobsson Støre
Principal Investigator

Karlstad University
Department of Social and Psychological Studies
Karlstad
65188
Sweden

ORCiD logoORCID ID 0000-0001-5749-0774
Phone +46 733019195
Email siri.store@kau.se

Study information

Study designMixed-methods study with an explanatory sequential design
Primary study designInterventional
Secondary study designNon randomised study
Study setting(s)Home
Study typeTreatment
Participant information sheet 43406 PIS (in Swedish).pdf
Scientific titleA robot intervention for adults with ADHD and insomnia - A mixed-method study
Study objectivesThe aims are to assess whether a three-week sleep robot intervention have individual effects in adults with adhd and insomnia, and how initial results can be understood in light of participants’ experiences with the robot.
Ethics approval(s)Approved 20/01/2021, Swedish Ethical Review Authority (Etikprövningsmyndigheten, Box 2110, 750 02, Uppsala, Sweden; +46 10-475 08 00; registrator@etikprovning.se), ref: DNR 2020-06975
Health condition(s) or problem(s) studiedInsomnia
InterventionA three-week sleep robot intervention with the Somnox sleep robot. Assessments were conducted daily for six weeks (sleep diary and wrist actigraphy), and pre- and post-intervention (questionnaires).

Recruitment happened through the university webpage and social media. Screening was conducted via phone (60-90 minutes). Participants were individually trained in how to use the sleep robot for 10-15 minutes. The intervention lasted for 21 days in participants’ homes. Participants were encouraged to use the robot each evening/night of the intervention phase. Daily subjective sleep measurements were obtained with a sleep diary for six consecutive weeks (two baseline weeks, three intervention weeks, and one post-intervention week) (approximately 5 minutes). The same sleep variables were also obtained objectively with wrist actigraphy for two weeks of the study: week 1 (baseline) and week 3 (intervention). Additionally, participants answered questionnaires at pre-intervention, mid-intervention, post-intervention, and 1-month follow-up (approximately 10 minutes).
Intervention typeDevice
Pharmaceutical study type(s)
PhaseNot Applicable
Drug / device / biological / vaccine name(s)Somnox sleep robot
Primary outcome measureSleep onset latency and wake after sleep onset: the Consensus Sleep Diary (daily for weeks 1-6 of the study) and actigraphy (week 1 and week 3).
Secondary outcome measures1. Total sleep time and sleep efficiency: the Consensus Sleep Diary (daily for weeks 1-6 of the study) and actigraphy (week 1 and week 3).
2. Insomnia severity was measured using the Insomnia Severity Index at baseline, mid-intervention (week 4), post-intervention (week 6), and at 1-month follow up (week 10).
3. Somatic arousal was measured using the Pre-Sleep Arousal Scale at baseline, post-intervention (week 6), and at 1-month follow up (week 10).
4. Anxiety and depression symptoms were measured using the Hospital Anxiety and Depression Scale at baseline, post-intervention (week 6), and at 1-month follow up (week 10).
5. ADHD symptoms were measured using the Adult ADHD Self-Report Scale at baseline, post-intervention (week 6), and at 1-month follow up (week 10).
Overall study start date01/12/2020
Completion date01/06/2023

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
SexBoth
Target number of participants6
Total final enrolment6
Key inclusion criteria1. Speak Swedish fluently
2. 18 years+ of age
3. Previously diagnosed with ADHD
4. Meet the diagnostic criteria of insomnia
Key exclusion criteria1. Meet the diagnostic criteria of another untreated sleep disorder
2. Meet the diagnostic criteria of another current psychiatric disorder
Date of first enrolment01/01/2022
Date of final enrolment01/04/2022

Locations

Countries of recruitment

  • Sweden

Study participating centre

Karlstad University
Department of Social and Psychological Studies
Karlstad
65188
Sweden

Sponsor information

Karlstad University
University/education

Department of Social and Psychological Studies
Karlstad
65188
Sweden

Phone +46 547001000
Email info@kau.se
Website https://www.kau.se/en
ROR logo "ROR" https://ror.org/05s754026

Funders

Funder type

University/education

Karlstads universitet
Government organisation / Universities (academic only)
Alternative name(s)
Karlstad University, KAU
Location
Sweden

Results and Publications

Intention to publish date01/01/2024
Individual participant data (IPD) Intention to shareYes
IPD sharing plan summaryAvailable on request
Publication and dissemination planPlanned publication in a high-impact peer-reviewed journal.
IPD sharing planThe datasets generated during and/or analysed during the current study will be available upon request from Siri Jakobsson Støre, siri.store@kau.se

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Participant information sheet in Swedish 29/03/2023 No Yes
Dataset 20/06/2023 No No
Protocol file 20/06/2023 No No
Protocol file 20/06/2023 No No
Protocol file 20/06/2023 No No
Protocol file 20/06/2023 No No
Statistical Analysis Plan 20/06/2023 No No
Statistical Analysis Plan 20/06/2023 No No
Results article 01/09/2023 09/10/2023 Yes No

Additional files

43406 PIS (in Swedish).pdf
in Swedish
ISRCTN11007746_PROTOCOL_English.pdf
ISRCTN11007746 _PROTOCOL_Swedish.pdf
ISRCTN11007746_PROTOCOL_Adjusted_English.pdf
ISRCTN11007746_PROTOCOL_Adjusted_Swedish.pdf
ISRCTN11007746_PROTOCOL_English.pdf
ISRCTN11007746 _PROTOCOL_Swedish.pdf
ISRCTN11007746 dataset.xlsx

Editorial Notes

09/10/2023: Publication reference added.
20/06/2023: Protocols, statistical analysis plan and dataset uploaded.
29/03/2023: Trial's existence confirmed by Swedish Ethical Review Authority (Etikprövningsmyndigheten)